Short report
Hypersensitivity pneumonitis associated with co-proxamol
(paracetamol + dextropropoxyphene) therapy
S P Matusiewicza, W A H Wallaceb, G K Cromptona
a Respiratory Unit,
Western General Hospital NHS Trust, Crewe Road South, Edinburgh EH4
2XU, UK, b Department of Pathology, University of
Edinburgh, Teviot Place, Edinburgh EH8 9AG, UK
Correspondence to: Dr G K Crompton
Accepted 14 January
1999
A 61-year-old man developed hypersensitivity pneumonitis and
skin rash in close association with taking co-proxamol. These problems
occurred in spite of being treated with prednisolone 40 mg daily (20 mg
daily at the time of presentation) for assumed cranial arteritis. A
therapeutic challenge with paracetamol was negative and the patient
continues to take this drug. It seems likely that this patient's rash
and hypersensitivity pneumonitis was caused by dextropropoxyphene.
Dextropropoxyphene has not been reported previously as a cause of
hypersensitivity pneumonitis.
Keywords: adverse drug reaction; hypersensitivity pneumonitis; co-proxamol; dextropropoxyphene
© 1999 by The Fellowship of Postgraduate Medicine
This article has been cited by other articles:
-
Wells, A U, Hirani, N, on behalf of the BTS Interstitial Lung Disease Gui,
(2008). Interstitial lung disease guideline. Thorax
63: v1-v58
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
